We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from... Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a "biological mask" with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Show more
Raanana, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of...
Raanana, Israel, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of...
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production...
Raanana, Israel, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0391 | 2.53896103896 | 1.54 | 1.5898 | 1.35 | 90021 | 1.44761185 | CS |
4 | -0.4209 | -21.045 | 2 | 2.66 | 1.26 | 1335263 | 2.06411791 | CS |
12 | -0.0609 | -3.71341463415 | 1.64 | 4.8 | 0.77 | 3357884 | 2.90998741 | CS |
26 | -0.0609 | -3.71341463415 | 1.64 | 4.8 | 0.77 | 3357884 | 2.90998741 | CS |
52 | -0.0609 | -3.71341463415 | 1.64 | 4.8 | 0.77 | 3357884 | 2.90998741 | CS |
156 | -0.0609 | -3.71341463415 | 1.64 | 4.8 | 0.77 | 3357884 | 2.90998741 | CS |
260 | -0.0609 | -3.71341463415 | 1.64 | 4.8 | 0.77 | 3357884 | 2.90998741 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions